DNCB test, peripheral blood lymphocyte count and total T -lymphocyte count have been,
measured in 28 patients with histologically proven adenocarcinoma of the stomach.
DNCB test was well correlated with the histologically proven stage of the cancer (The grade of the DNCB=-0.72XNo of stage+3.08, p<0.001).
The peripheral lymphocyte count and total T-lymphocyte count did not so well be correlated as the response to DNCB, but were also correlated with the pathologic stage of the cancer (F=-6.-85, .p<0. 005 of the. T-lymphocyte, and F=3.95, P<0. 005 of, the peripheral lymphocyte).
Total T-lymphocyte count was correlated with the delayed hypersensitivity response to DNCB of the patient and the percentage of T-lymphocytes in the total peripheral lymphocytes was well. correlated with the pathologic stage.
There was significant correlation between the T-lymphocyte count and the response to DNCB, but no correlation between the peripheral lymphocyte count and the response to DNCB was found.
The patients with the cancer, of advanced stage- showed poor response to DNCB and had low T-lymphocyte and peripheral., lymphocyte count. Those patients with poor response to DNCB tended to have low T-lymphocyte count.
|